1
CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
Condition(s):Hematologic Malignancy; Acute Myeloid Leukemia; Myelodysplastic Syndromes; Myeloproliferative Neoplasm; Chronic Myeloid LeukemiaLast Updated:November 12, 2019Unknown status